SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-043357
Filing Date
2021-11-05
Accepted
2021-11-05 17:31:37
Documents
1
Period of Report
2021-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6125
  Complete submission text file 0000899243-21-043357.txt   8823
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V GP Manager, Ltd. (Reporting) CIK: 0001641348 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 211385842

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V, L.P. (Reporting) CIK: 0001641354 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 211385844

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V GP, L.P. (Reporting) CIK: 0001641355 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 211385843

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations